Baxion
ScreeningTagsAlerts

Translational Development Acquisition Corporation.

TDAC·NASDAQ·$10.65Share Price as of 11/2·$233MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/2610-QQ1 ended 03/31/2605/15/2610-K/AFY 202505/11/2610-K/AFY 202505/06/2610-KFY 202503/30/26

Disclosures

8-KCurrent report07/27/268-KCurrent report07/08/268-KCurrent report06/23/268-KCurrent report06/18/268-KCurrent report06/12/26

Prospectuses and Registrations

424B4Prospectus12/23/24S-1/ARegistration statement (amended)12/19/24S-1/ARegistration statement (amended)11/20/24S-1Registration statement (IPO)10/22/24S-1Registration statement (IPO)08/26/22

Proxies

DEFA14AAdditional proxy materials06/23/26DEFA14AAdditional proxy materials05/28/26DEF 14ADefinitive proxy05/27/26PRE 14APreliminary proxy05/01/26

Ownership

SC 13GBeneficial ownership08/14/26SC 13G/ABeneficial ownership (amended)08/14/26SC 13G/ABeneficial ownership (amended)08/12/26SC 13G/ABeneficial ownership (amended)07/16/26SC 13GBeneficial ownership06/02/26

Other

42542510/08/2642542509/24/2642542509/14/2642542508/03/2642542507/28/26

Latest Filings

42542510/08/2642542509/24/2642542509/14/2610-QQ2 ended 06/30/2608/14/2642542508/03/26

Ownership

SC 13GBeneficial ownership08/14/26SC 13G/ABeneficial ownership (amended)08/14/26SC 13G/ABeneficial ownership (amended)08/12/26SC 13G/ABeneficial ownership (amended)07/16/26SC 13GBeneficial ownership06/02/26
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact